| 
			
			 AstraZeneca vaccine 76% effective in new analysis of U.S. trial 
 AstraZeneca said its COVID-19 vaccine was 76% effective at 
			preventing symptomatic illness in a new analysis of its major U.S. 
			trial - slightly lower than the 79% level announced this week in a 
			report that was criticised for using outdated information.
 
 The latest data was based on 190 infections among more than 32,400 
			participants in the United States, Chile and Peru. AstraZeneca said 
			it planned to seek U.S. emergency use authorisation in the coming 
			weeks and the latest data had been presented to the independent 
			trial oversight committee, the Data Safety Monitoring Board.
 
			
			 
			
 India delays big AstraZeneca vaccine exports as infections surge
 
 India has put a temporary hold on all major exports of the 
			AstraZeneca coronavirus shot made by the Serum Institute of India, 
			the world's biggest vaccine-maker, to meet domestic demand as 
			infections rise, two sources told Reuters.
 
 Prime Minister Narendra Modi's cabinet decided this week to widen 
			its inoculation drive by including everyone above 45 from April 1, 
			and many states battling a surge in infections have demanded that 
			all adults be covered.
 
 US says it hopes WHO report on virus origins is "based on science"
 
			
            [to top of second column] | 
			
			 The United States expects a 
								World Health Organization (WHO) investigation 
								into the origins of the novel coronavirus 
								pandemic to require further study, perhaps 
								including a return visit to China, a senior U.S. 
								official said on Wednesday.
 The lengthy report by the team - made up of 
								international experts and their Chinese 
								counterparts - is expected to be issued this 
								week, the WHO says.
 
 UK's Johnson considers tougher rules for France
 
 Britain might have to toughen restrictions on 
								arrivals from France, including hauliers, to 
								defend against new variants of the COVID-19 
								virus spreading from the rest of Europe where 
								the situation was difficult, Prime Minister 
								Boris Johnson said.
 
 Asked whether France should be put on a red 
								list, which is a category of countries from 
								which most travel to Britain is banned, Johnson 
								told a parliamentary committee that testing 
								hauliers would have an impact on trade flows.
 
 (Compiled by Karishma Singh)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content 
			
			 |